MEGAN STRAUER: Open Payments
NPI 1598315764 · KALIDA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 41 payments from 12 companies in 2025. Trend: 2023 $510 · 2024 $746 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Lucid Diagnostics Inc. | 12 | $234 |
| ABBVIE INC. | 12 | $141 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Novo Nordisk Inc | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, VOQUEZNA, MOUNJARO, QULIPTA, AIRSUPRA, Ozempic, PREVNAR 20, LEQVIO.
Industry payments across OH — which companies pay providers there.
